Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients

AIM: To elucidate influencing factors of treatment response, then tolvaptan has been approved in Japan for liquid retention. METHODS: We herein conducted this study to clarify the influencing factors in 40 patients with decompensated liver cirrhosis complicated by liquid retention. Tolvaptan was adm...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastroenterol
Hlavní autoři: Nakagawa, Ai, Atsukawa, Masanori, Tsubota, Akihito, Kondo, Chisa, Okubo, Tomomi, Arai, Taeang, Itokawa, Norio, Narahara, Yoshiyuki, Iwakiri, Katsuhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2016
Témata:
Prospective Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886386/
https://ncbi.nlm.nih.gov/pubmed/27275103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i21.5104
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky